Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
2,205.00
+175.00 (8.62%)
At close: Sep 11, 2026
Kyung Nam Pharm Revenue
Kyung Nam Pharm had revenue of 17.81B KRW in the quarter ending June 30, 2026, with 10.68% growth. This brings the company's revenue in the last twelve months to 54.89B, down -12.34% year-over-year. In the year 2024, Kyung Nam Pharm had annual revenue of 60.79B with 2.51% growth.
Revenue (ttm)
54.89B
Revenue Growth
-12.34%
P/S Ratio
0.79
Revenue / Employee
225.89M
Employees
243
Market Cap
43.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 60.79B | 1.49B | 2.51% |
| Dec 31, 2023 | 59.30B | 303.06M | 0.51% |
| Dec 31, 2022 | 59.00B | -5.62B | -8.70% |
| Dec 31, 2021 | 64.62B | -6.31B | -8.89% |
| Dec 31, 2020 | 70.93B | 26.13B | 58.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 195.70B |
| RP Bio | 141.42B |
| Jin Yang Pharmaceutical | 124.61B |
| Sinsin Pharmaceutical | 123.05B |
| Hwail Pharmaceutical | 107.87B |
| GeneBioTech Co. ,Ltd | 89.31B |
| Sinil Pharmaceutical | 86.82B |
| Korean Drug | 65.39B |